Table 3.
Patient and Provider Characteristics by Delay Group
| Characteristics | Patients with delayed follow-up (n=163) | Patients with no delayed follow-up (n=108) | P value (Fisher’s or chi-square tests where appropriate) |
|---|---|---|---|
| Age [mean (SD)] | 62.8 (15.5) | 62.2 (16.6) | 0.32 (t test) |
| Gender [n (%)] | |||
| Male | 147 (90.2%) | 93 (86.1%) | 0.33 |
| Female | 16 (9.8%) | 15 (13.9%) | |
| Race [n (%)] | |||
| American Indian/Alaskan Native | 4 (2.5%) | 0 (0.0%) | 0.09 |
| Black/African American | 37 (22.7%) | 16 (14.8%) | |
| Native Hawaiian/Pacific Islander | 0 (0.0%) | 2 (1.9%) | |
| White | 103 (63.2%) | 77 (71.3%) | |
| White-non Hispanic | 4 (2.5%) | 1 (0.9%) | |
| Unknown | 15 (9.2%) | 12 (11.1%) | |
| Diabetes [n (%)] | |||
| No | 120 (73.6%) | 79 (73.1%) | ∼1.00 |
| Yes | 43 (26.4%) | 29 (26.9%) | |
| Hypertension [n (%)] | |||
| No | 45 (27.6%) | 42 (38.9%) | 0.06 |
| Yes | 118 (72.4%) | 66 (61.1%) | |
| Hyperlipidemia [n (%)] | |||
| No | 66 (40.5%) | 42 (38.9%) | 0.80 |
| Yes | 97 (59.5%) | 66 (61.1%) | |
| Obesity [n (%)] | |||
| No | 107 (65.6%) | 74 (68.5%) | 0.69 |
| Yes | 56 (34.4%) | 34 (31.5%) | |
| Depression [n (%)] | |||
| No | 141 (86.5%) | 99 (91.7%) | 0.24 |
| Yes | 22 (13.5%) | 9 (8.3%) | |
| TSH ordering provider [n (%)] | |||
| Specialist | 22 (13.5%) | 9 (8.3%) | 0.24 |
| PCP | 141 (86.5%) | 99 (91.7%) | |
| Person primarily managing patient’s thyroid disease [n (%)] | |||
| PCP | 152 (93.3%) | 93 (86.1%) | 0.15 |
| Endocrinologist | 7 (4.3%) | 10 (9.3%) | |
| Unknown or None | 4 (2.5%) | 5 (4.6%) | |
| Type of PCP patient regularly sees [n (%)] | |||
| Physician | 130 (79.8%) | 83 (76.9%) | 0.65 |
| Nurse practitioner or physician’s assistant | 33 (20.2%) | 25 (23.1%) | |
| Prior PCP visit [n (%)] | |||
| No | 6 (3.7%) | 3 (2.8%) | ∼1.00 |
| Yes | 157 (96.3%) | 105 (97.2%) | |
| Prior endocrine visit [n (%)] | |||
| No | 148 (90.8%) | 96 (88.9%) | 0.68 |
| Yes | 15 (9.2%) | 12 (11.1%) | |